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Measuring the gap to universal health coverage
Universal health coverage (UHC) is a fundamental global 
public health objective. It is part of the Sustainable 
Development Goals1 and a strategic priority of the World 
Bank and WHO.2 UHC includes access to quality essential 
health-care services for all. In The Lancet Public Health, 
Mark Moses and colleagues3 assess the evolution of 
outpatient visits and inpatient admissions by age and 
sex for 195 countries from 1990 to 2016. The study also 
estimates the main drivers of the changes in volumes 
of outpatient visits and inpatient admissions, as well 
as their unit costs. The costs required to close the gap 
in UHC are then calculated by multiplying these unit 
costs with the additional health-care services required to 
meet a UHC standard for utilisation. 
Moses and colleagues found utilisation rates varying 
across countries by a factor of ten. High-income 
countries generally had higher utilisation rates than did 
low-income countries but there were many exceptions 
to this pattern. The range in unit cost estimates was 
much larger than in utilisation rates, with costs (in 
international dollars [I$]) per outpatient visit ranging 
from I$2 in several African countries to I$478 in the 
USA and costs per inpatient admission ranging from 
I$87 in the Central African Republic to I$22 543 in 
the USA. Selecting the Netherlands as reference for a 
UHC standard of utilisation, the additional global cost 
to meet this standard amounted to I$1177·69 billion 
(95% uncertainty interval 896·05–1456·56). Globally, 
only seven other countries reached this standard, most of 
which were European. However, a third of the remaining 
countries would incur in costs below 1% of their gross 
domestic product (GDP) to reach the reference UHC 
standard for utilisation. Conversely, another third of 
countries would incur in costs between 2% and 5% of 
GDP, and 23 countries in costs greater than 5% of GDP.
Progress to UHC standard was somewhat sobering 
because the substantial increase in outpatient visits and 
inpatient admissions from 1990 to 2016 was mainly 
driven by population growth and ageing and only 
marginally by increasing utilisation rates. Nevertheless, 
there was a substantial increase in utilisation rates in 
some countries such as China, Indonesia, and Turkey. 
The study makes a substantial contribution to a better 
understanding of the challenges in reaching UHC. The 
global assessment of the current levels of outpatient 
visits and inpatient admissions by combining and 
harmonising a massive number of data sources is 
remarkable, as is the decomposition of changes in 
utilisation over time. Previous assessments have 
mainly focused on the provision of essential services 
and the availability of health-care resources2 and on 
health service utilisation rates in high-income countries 
rather than in their low-income and middle-income 
counterparts.4
The study also makes several methodological 
contributions. The most challenging task is probably 
the need to determine the gap in health-care utilisation 
in relation to the country-specific disease burden, as 
measured by disability-adjusted life-years (DALYs). This 
is crucial because a higher disease burden will require 
more health-care services to reach UHC but improved 
access and quality of health care will simultaneously 
contribute to a reduction in disease burden. Moses 
and colleagues thus estimated a standardised disease 
burden by removing the effects of access and quality 
of health care.3 This procedure illustrates the value of 
the Global Burden of Disease project5 for furthering 
research and health policy. The unit costs of outpatient 
visits and inpatient admissions were calculated by using 
the National Health Accounts and estimated utilisation 
rates,3 a procedure that is likely to be useful in further 
studies. 
The study results also reveal some of the remaining 
challenges in determining a UHC standard for utilisation 
and the costs of reaching this standard. First, the quality 
of health-care services is likely to differ substantially 
between countries. This is illustrated by the much higher 
gap in purchasing power-adjusted health-care spending 
than in health-care utilisation rates. Comparing, for 
example, India and the Netherlands in 2015, we find a 
ratio of one to 22·4 per-capita health-care spending,6 
whereas Moses and colleagues find a ratio of one to 
1·6 for outpatient visits per counterfactual DALY and of 
one to 2·4 for inpatient admissions per counterfactual 
DALY. This large difference is most likely also due 
to a substantial difference in the quality of services; 
for example, several studies have documented the 
often very low quality of care in India7 or the lack of 
access to basic surgical procedures in hospitals in 
many low-income countries.8 Second, inefficiencies 
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in current health-care systems should be considered 
when calculating the additional costs of UHC. These 
inefficiencies might affect the production of health-
care services as well as the type of services provided. 
The Netherlands appear to be relatively efficient in this 
regard9 and certainly more so than the USA.10 The costs 
required to close the gap in UHC will thus be affected by 
the cost of the increased service quality required to meet 
the standard in the reference country, as well as by the 
efficiency in the production of these health-care services.
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